Gal-3 is a beta-galactoside-binding lectin that presents an increased expression in fibrotic tissues and acts as a regulator of fibrosis and inflammation, being considered an emerging biomarker for cardiovascular diseases28,29, especially for the cardiac remodelling that takes place in AF patients30. This evidence concerns the gene LGALS3 and atrial fibrillation.